Experienced in Shingles

Dr. Joe E. Pouzar

Specialty Associates Of West Houston PLLC
Houston, TX
Experienced
in Shingles
Specialties:Family Medicine
Accepting New Patients
Offers Telehealth
OverviewInsuranceLocationsClinical Research

Overview

Joe Pouzar is a Family Medicine provider in Houston, Texas. Dr. Pouzar and is rated as an Experienced provider by MediFind in the treatment of Shingles. His top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Type 2 Diabetes (T2D). Dr. Pouzar is currently accepting new patients.

His clinical research consists of participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Family Medicine
Licenses
Family Medicine in TX
Hospital Affiliations
Houston Methodist Clear Lake Hospital
Hca Houston Healthcare Clear Lake
Languages Spoken
English
Spanish
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Community Health
  •  Friday Health
  •  Oscar
  •  UnitedHealthcare
  •  Humana

Locations

SPECIALTY ASSOCIATES OF WEST HOUSTON PLLC
1045 Gemini St, Suite 200b, Houston, TX 77058
281-461-6830
Other Locations
SPECIALTY ASSOCIATES OF WEST HOUSTON PLLC
1140 Business Ctr Dr, Suite 490, Houston, TX 77043
713-932-1247
SPECIALTY ASSOCIATES OF WEST HOUSTON PLLC
15200 Southwest Fwy, Suite 290, Sugar Land, TX 77478
281-980-2010
SPECIALTY ASSOCIATES OF WEST HOUSTON PLLC
450 W Med Ctr Blvd, Webster, TX 77598

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
Enrollment Status: Terminated
Publish Date: February 20, 2025
Intervention Type: Biological, Drug
Study Drug: RSV Maternal vaccine
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A 12-Month, Open-Label Safety Study of Simufilam Followed by a 6-Month Randomized Withdrawal and 6 Additional Months Open-Label in Mild-to-moderate Alzheimer's Disease Patients
A 12-Month, Open-Label Safety Study of Simufilam Followed by a 6-Month Randomized Withdrawal and 6 Additional Months Open-Label in Mild-to-moderate Alzheimer's Disease Patients
Enrollment Status: Completed
Publish Date: December 26, 2023
Intervention Type: Drug
Study Drug: Simufilam
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-Alcoholic Fatty Liver Disease (NAFLD) - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-Alcoholic Fatty Liver Disease (NAFLD) - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
Enrollment Status: Completed
Publish Date: May 25, 2023
Intervention Type: Other, Dietary supplement, Combination product
Study Phase: Phase 2
A Phase III, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 to Treat Chronic Nonhealing Foot Ulcers in Diabetic Patients With Concomitant Peripheral Arterial Disease (PAD)
A Phase III, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 to Treat Chronic Nonhealing Foot Ulcers in Diabetic Patients With Concomitant Peripheral Arterial Disease (PAD)
Enrollment Status: Terminated
Publish Date: February 22, 2023
Intervention Type: Genetic, Drug
Study Phase: Phase 3
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Biomarker and Safety Study of PTI-125 in Mild-to-moderate Alzheimer's Disease Patients
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Biomarker and Safety Study of PTI-125 in Mild-to-moderate Alzheimer's Disease Patients
Enrollment Status: Completed
Publish Date: September 29, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized Double-Blind Study Comparing Oseltamivir Versus Placebo for the Treatment of Influenza in Low Risk Adults
A Randomized Double-Blind Study Comparing Oseltamivir Versus Placebo for the Treatment of Influenza in Low Risk Adults
Enrollment Status: Completed
Publish Date: February 05, 2019
Intervention Type: Drug
Study Phase: Not Applicable
View 10 Less Clinical Trials
Similar Doctors
Expertise in
36
conditions
Dr. John L. Redman
Family Medicine
Expertise in
36
conditions
Dr. John L. Redman
Family Medicine

Chambers County Public Hospital District No. 1

Anahuac, TX 
 (32.4 mi)
409-267-4126
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

John Redman is a Family Medicine provider in Anahuac, Texas. Dr. Redman and is rated as an Advanced provider by MediFind in the treatment of Shingles. His top areas of expertise are Sinusitis, Cellulitis, Empyema, and Hypertensive Heart Disease. Dr. Redman is currently accepting new patients.

Expertise in
11
conditions
Dr. Arun N. Kumar
Family Medicine
Expertise in
11
conditions
Dr. Arun N. Kumar
Family Medicine

Arun Kumar MD PA

10726 Huffmeister Rd, Suite 100, 
Houston, TX 
 (39.0 mi)
281-477-0666
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Arun Kumar is a Family Medicine provider in Houston, Texas. Dr. Kumar and is rated as an Advanced provider by MediFind in the treatment of Shingles. His top areas of expertise are Diverticular Disease, End-Stage Renal Disease (ESRD), Shingles, Gastrostomy, and Endoscopy. Dr. Kumar is currently accepting new patients.

Expertise in
11
conditions
Dr. Victor S. Sierpina
Family Medicine
Expertise in
11
conditions
Dr. Victor S. Sierpina
Family Medicine
301 University Blvd, 
Galveston, TX 
 (26.4 mi)
409-744-4030
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Victor Sierpina is a Family Medicine provider in Galveston, Texas. Dr. Sierpina and is rated as an Advanced provider by MediFind in the treatment of Shingles. His top areas of expertise are Bell's Palsy, Recurrent Peripheral Facial Palsy, Facial Paralysis, and Familial Neurocardiogenic Syncope. Dr. Sierpina is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile